Sermorelin cost in 2026: per-month pricing, the intro-vs-renewal trap, and what your subscription buys

Sermorelin is the quiet default of the telehealth peptide market — the growth-hormone-releasing analog most healthy adults are actually prescribed when they sign up for “peptide therapy.” Because it’s sold the way streaming services are — a recurring monthly charge with an attractive first-order rate — the sticker you see at signup is rarely the sticker you pay six months in. This page breaks down what sermorelin really costs: provider by provider, injection versus oral, and how to read a subscription plan on a true per-month basis so the headline number can’t mislead you.

Why sermorelin is priced as a subscription, not a prescription

Start with the fact that reshapes every number below: sermorelin sold for adult “vitality” is 100% compounded and 100% cash-pay. There is no insurance lane, no copay, no pharmacy-benefit negotiation — because boosting the growth-hormone axis in a healthy adult isn’t a covered medical indication. The branded injectable left the U.S. market years ago for business reasons, so today the molecule reaches patients almost entirely through compounding pharmacies working with telehealth platforms.^[1] That structure is exactly why it’s billed as a subscription. You are paying, month after month, for three things bundled together: the clinician consult and ongoing prescription, the compounded medication itself, and the logistics of getting it shipped — not for a rare or expensive drug. Sermorelin is cheap to compound. The recurring fee is a convenience-and-access fee wearing a vial.

Provider-by-provider: what sermorelin costs in mid-2026

Pricing clusters tightly once you normalize it to a per-month figure, but the way each provider frames that figure differs sharply — some lead with a discounted first month, others quote a flat plan rate. The table below collects verified rates from across the major sellers. Treat every figure as mid-2026 and confirm the current rate at signup, because intro promotions and plan tiers change frequently.

Read that table for the pattern, not just the numbers. Eden’s “from ~$126” and Invigor’s “~$163 first month” are both anchored on the first order — the rates you compare against renewal, not the rates you pay indefinitely. Yucca’s ~$192 is quoted as a per-month figure on a three-month plan, which is a more honest way to present it because there’s no hidden step-up baked in. Shed’s flat ~$149 sits in between. Once you push all of these onto a true steady-state, per-month basis, the legitimate compounded market lands in roughly the $120–$200 a month range, with the spread driven almost entirely by plan length and whether you’re still inside an intro window.

Injection vs oral (ODT): same molecule, similar money

Sermorelin comes two ways through telehealth: a subcutaneous injection (the classic format) and an oral fast-dissolve troche or tablet — the ODT, or orally-disintegrating, route that some providers like Eden offer for needle-averse patients. The cost question people expect to be decisive usually isn’t: the two formats are typically priced in the same neighborhood, because the underlying compounded peptide is the cost driver, not the delivery vehicle. What differs is practical. Injection is the better-characterized route for getting peptide into circulation predictably; oral dissolvable formats trade some of that pharmacokinetic certainty for the comfort of skipping the needle. If you’re weighing the two, decide on format preference and absorption first and let price be the tiebreaker, not the headline — and read our sermorelin dosage guide for how each route is actually dosed.

The cost drivers, and how to compare plans fairly

Three levers move the sermorelin number, and only some are in your control:

1. Plan length. This is your biggest lever. A three- or six-month commitment almost always lowers the per-month rate versus month-to-month, which is why Yucca’s ~$192 is quoted against a three-month plan. Flexibility costs a premium; commitment buys a discount. If you’ve already decided to try sermorelin and have read the side-effect profile, a multi-month plan is usually the cheaper path — just be sure you understand the cancellation terms before locking in.

2. The intro-vs-renewal step-up. The first-order discount is a customer-acquisition tactic, and it works precisely because the renewal rate is quieter. To compare two providers fairly, line up their renewal prices, not their intro prices. A plan that’s “cheaper” in month one can be the more expensive one by month four.

3. What’s actually in the bundle. Some monthly fees include clinician check-ins, dose adjustments and shipping; others tack those on. A slightly higher all-in plan that includes follow-up care can be better value than a bare-bones medication-only rate that bills extra for every consult. Normalize to a true per-month, everything-included figure before you decide which plan is genuinely cheapest.

Cost vs evidence: what you’re actually buying

Here is the part the pricing pages skip. Sermorelin reliably does one measurable thing in adults: it nudges the pituitary to release growth hormone, and growth-hormone secretagogues raise IGF-1, a biomarker.^[2] But raising a lab value is not the same as buying a proven outcome. The adult anti-aging case — more muscle, better recovery, reversed aging — rests on shifted lab values plus a handful of narrowly targeted studies, not on large trials of hard healthspan endpoints. We won’t re-argue that here; the full read, including what sermorelin was genuinely approved for, is in our sermorelin evidence review. The cost takeaway follows directly: you’re paying outcome-sounding prices for biomarker-deep evidence, so the spend only makes sense if you go in clear-eyed about what the money buys. To see how sermorelin grades against the rest of the field before you subscribe, our peptide evidence matrix scores each peptide on the strength of its support.

How sermorelin’s cost compares to its closest alternatives

Sermorelin rarely gets shopped in isolation — people weigh it against the two peptides most often mentioned in the same breath. Tesamorelin is a related GHRH analog, but it’s an approved biologic for a specific medical indication and sits in a far higher price tier; we break its numbers down in the tesamorelin cost guide. MK-677is an oral secretagogue that’s typically sold even more cheaply through the gray market, which carries its own content-and-safety risk rather than a true discount. And if you want to see the photos people expect their spend to deliver, weigh them honestly against our sermorelin before-and-after reality check. For the full landscape of routes and what each tier of “peptide therapy” costs, see our peptide therapy cost breakdown.

The honest bottom line

Compounded sermorelin costs what a cash-pay telehealth subscription costs — realistically $120–$200 a month at steady state, with intro rates dipping lower and a few plans landing higher. The single most important move isn’t hunting for the lowest first-month number; it’s reading past the intro hook to the renewal rate, normalizing each plan to a true per-month, everything-included figure, and using plan length as your lever. Injection and oral cost about the same, so pick on preference. And before any of that, anchor the spend to the evidence: sermorelin moves a biomarker more convincingly than it moves a proven outcome. To compare the legitimate providers head to head on what they charge and how they handle follow-up, see our peptide therapy provider comparison.